Genetic Technology Alert. A Fully Integrated, High Capacity, Next Generation Sequencing System; Ebola Diagnostic Kit by China Approved by the World Health Organization; CRISPR Associated Protein 9 Mediated Gene Editing in Human Embryo

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles a fully integrated, high capacity, next generation sequencing system; an ebola diagnostic kit by China that has been approved by the WHO; and CRISPR associated protein 9 mediated gene editing in human embryo.

Table of Contents

Genetic Technology Alert. A Fully Integrated, High Capacity, Next Generation Sequencing System; Ebola Diagnostic Kit by China Approved by the World Health Organization; CRISPR Associated Protein 9 Mediated Gene Editing in Human EmbryoIn This Issue1. A FULLY INTEGRATED, HIGH CAPACITY, NEXT GENERATION SEQUENCING SYSTEM2. EBOLA DIAGNOSTIC KIT BY CHINA APPROVED BY THE WORLD HEALTH ORGANIZATION3. CRISPR ASSOCIATED PROTEIN 9 MEDIATED GENE EDITING IN HUMAN EMBRYO4. RECENT PATENTS IN GENE THERAPY IN CHINA5. TECHVISION 2015




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.